Hypatia Announces Michael Hillegass as Director of Sales and Business Development

In this new role, Michael Hillegass, MBA will oversee all sales and business development efforts for both public and commercial sectors, building upon Hypatia’s work with the United States Department of Commerce, the Department of Defense, the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), as as well as with biotechnology companies.

“I am very excited to be joining Hypatia,” said Hillegass. “Not only am I impressed with the entire team, but they are building cutting edge technologies, providing artificial intelligence infrastructure, blockchain protocols, and precision medicine solutions to high-profile customers, from Dell Technologies to the Joint Artificial Intelligence Center (JAIC) and the FDA Oncology Center of Excellence. The past performance Hypatia has built in only a few short years, including its recent re-award as a Data Innovation Joint Venture Partner to the United States Department of Commerce NTIS, provides unique opportunities to develop solutions for mission leaders, federal laboratories and industry. I look forward to building upon this portfolio of milestone achievements and working with Hypatia’s Collaboratory of Experts.”

Read the full press release here.